Leading science-based ayurveda major Dabur India reported a 7.7% growth in consolidated revenue for the fourth quarter ended 31 March 2022, on a high 25% base of the previous year. The full-year consolidated revenue for 2021-22 grew 14% year-on-year to cross the Rs 10,000 crore landmark.

On 5 May 2022, the Board of Directors met in New Delhi to consider the audited financial results of the company for the quarter and full-year ended 31 March 2022.

Dabur delivered another quarter with steady revenue growth. The company reported a consolidated revenue growth of 7.7% at Rs 2,518 crore in the fourth quarter of the 2021-22 financial year, up from Rs 2,337 crore in the same quarter a year ago. Consolidated revenue for the quarter reported a 2-year CAGR of 16.2%, reflecting the remarkable agility and resilience the business continues to demonstrate even in a tough market.

Riding on consistent performance, backed by sustained efforts, Dabur ended the full-year 2021-22 with a consolidated revenue of Rs 10,889 crore, up 14% from Rs 9,562 crore in 2020-21. Net Profit before exceptional items for 2021-22 fiscal reported a 7.7% jump to Rs 1,824 crore, up from Rs 1,693 crore a year ago.

"The dramatic rise in input costs was the major challenge during the quarter. We responded to this challenge with a mix of pricing actions and cost control measures. These are challenging times, and we are happy to have progressed well in this journey with consumer-centric innovations to expand our total addressable market and gain market share across 99% of our product portfolio. Innovation continued to be the cornerstone of our strategy with new launches contributing to 5% of our Revenue. The year 2021-22 was a strong year for Dabur as we ended with an industry-leading Revenue growth of 13.8% in our India business, with an underlying FMCG Volume Growth of 10.1% for the full year. We also ended the year with a 15.8% constant currency growth in the International business," said Dabur India, chief executive officer Mohit Malhotra.

Dabur braved the inflationary headwinds to end the quarter with a 0.4% growth in net profit before exceptional items at Rs 379 crore. An impairment of Goodwill in respect of Hobi Kozmetic, Turkey, amounting to Rs 85 Crore was provided, due to the steep devaluation in Turkish currency over the past one year. Including this impairment, reported net profit for the fourth quarter of 2021-22 stood at Rs 294 crore. The high currency devaluation notwithstanding, Dabur's Turkey business reported a strong operational performance with a 47% growth in local currency during the quarter.

Malhotra said, "We have reported strong organic growth, with broad-based market share gains, following disciplined execution, rapid consumer-centric innovation, and increased digitalization. Despite the near-term concerns around heightening inflationary pressures and a resultant consumption slowdown, Dabur will continue to plough investments behind our power brands, coupled with investment in expanding the rural footprint and enhancing the go-to-market approach to drive sustainable, profitable growth, going forward," .

Dabur has invested ahead of the curve in expanding its rural coverage and today reaches around 90,000 villages. "We have added 30,000 new villages to our network in the past one year alone," Malhotra added.